loader
Please Wait
Applying Filters...

Seqens Seqens

X

List of chemical intermediates, fine chemicals supplied/manufactured for 138401-24-8

Client Virtual Booth
Menu
Filters Filter
Cross PopUp
FILTER :

filter

01 Sanpra Synthesis (1)

02 Smilax Laboratories Limited (1)

03 Zhejiang Huahai Pharmaceutical Co., Ltd. (1)

filter

01 138401-24-8 (3)

filter

01 China (1)

02 India (2)

URL Supplier Web Content
138401-24-8
Irbesartan
Sanpra Synthesis strongly believes that with its expertise and innovative pharmaceutical business ba...
Sanpra Synthesis strongly believes that with its expertise and innovative pharmaceutical business background, it is aptly positioned for APIs and intermediates manufacturing and outsourcing for the global market. We also undertake custom synthesis and contract manufacturing. Setting up multiple c GMP-manufacturing facility and world-class R&D center located in Vizag APSEZ De-notified area with well connected to road, rail, and air enabling cargo movement to the nearest transport facility in commercial production from January 2020.
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
URL Supplier Web Content
138401-24-8
Irbesartan
Smilax Laboratories Limited is a research-driven, vertically integrated pharmaceutical company manuf...
Smilax Laboratories Limited is a research-driven, vertically integrated pharmaceutical company manufacturing Active Pharmaceutical Ingredients, API Intermediates and NDDS/Pellets for the generics market across the world. Set up in 2005, Smilax has emerged a reliable supplier of generic products in the global market today. Set up in 2005, Smilax has emerged a reliable supplier of generic products in the global market today.Set up in 2005, Smilax has emerged a reliable supplier of generic products in the global market today. Smilax manufactures APIs and API Intermediates at its state-of-the-art manufacturing facilities located at Hyderabad, Telangana and Visakhapatnam, Andhra Pradesh, India. Supported by a highly qualified and competent technical team, and endowed with strengths in research and development, Smilax continues to expand its presence in the world of pharmaceuticals.
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content

1-{2-cyanobiphenyl-4yl)methyl}-2-N-butyl-4-spirocyclopentane-2...

URL Supplier Web Content
138401-24-8
Irbesartan
Zhejiang Huahai Pharmaceuticals Co., Ltd.was initially founded in 1989, and the company's stock was ...
Zhejiang Huahai Pharmaceuticals Co., Ltd.was initially founded in 1989, and the company's stock was successfully listed in Shanghai Stock Exchange in March, 2003. Huahai Pharmaceuticals, a large scaled modern pharmaceutical group that integrates fomulations, APIs(Active Pharmaceutical Ingredients) and intermediates, is developing both domestic and international markets, and performing parallel development of science, industry and commerce. With a total asset of 1,900 million yuan, the company has 11branches (subsidiaries) in the United States, Shanghai, Hangzhou, and Linhai.
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content

Looking for CAS 138401-24-8 ?

Looking for CAS 138401-24-8 ? 3

19

Sanpra Synthesis, based in India, is a pharmaceutical company.

One of their notable product Cyano Irbesartan with CAS Number 138401-24-8.


and End Use API Irbesartan

18

Smilax Laboratories Limited, based in India, is a pharmaceutical company that stands out with its certifications from EDQM and WHO-GMP.

One of their notable product 1-[(2'-Cyanobiphenyl-4-yl)methyl]-2- n-butyl-4-spirocyclopentane- 2- imidazoline-5-one with CAS Number 138401-24-8.


and End Use API Irbesartan

17

Zhejiang Huahai Pharmaceutical, based in China, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.

One of their notable product 1-{2-cyanobiphenyl-4yl)methyl}-2-N-butyl-4-spirocyclopentane-2-imidazoli-5-one HCL ( hexane free) with CAS Number 138401-24-8.


and End Use API Irbesartan

Post Enquiry
POST ENQUIRY